{"transactions":[{"id":1843293,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-27T18:11:40.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Stock Option shall vest and become exercisable in full on the earlier of (A) the date of the annual meeting of the Company's stockholders next following the grant\ndate and (B) on the first anniversary of the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":4.81,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001846253-23-000086","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000184625323000086/primary_doc.xml","form_type":"4"}},{"id":1843292,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-27T18:11:40.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (A) the\ndate of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (A) the\ndate of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on the earlier of (A) the\ndate of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the date of grant."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001846253-23-000086","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000184625323000086/primary_doc.xml","form_type":"4"}},{"id":2038309,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-02-01T14:29:24.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":37840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option fully vests on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) on the first Grant Date Anniversary."}],"balance_after":37840,"derivative":{"exercise_price":4.25,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":37840},"source":{"system":"sec-edgar","filing":"0001846253-23-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000184625323000012/edgardoc.xml","form_type":"4"}},{"id":2038308,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T14:29:24.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":8753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSU fully vests on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) on the first Grant Date Anniversary."}],"balance_after":224265,"source":{"system":"sec-edgar","filing":"0001846253-23-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000184625323000012/edgardoc.xml","form_type":"4"}},{"id":2119808,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T18:45:54.000Z","date":"2022-11-09","kind":"purchase","acquired":true,"shares":43000,"price":2.77,"value":119110.0,"ownership":{"direct":true},"balance_after":215512,"source":{"system":"sec-edgar","filing":"0000899243-22-035565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035565/doc4.xml","form_type":"4"}},{"id":2126409,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-11-04T01:06:59.000Z","date":"2022-11-01","kind":"disposition_to_issuer","acquired":false,"shares":4340,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and is exercisable on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders following the grant date or (ii) on June 10, 2023."}],"balance_after":0,"derivative":{"exercise_price":90.68,"expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":4340},"source":{"system":"sec-edgar","filing":"0000899243-22-035039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322035039/doc4.xml","form_type":"4"}},{"id":2126408,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common Stock","published_at":"2022-11-04T01:06:59.000Z","date":"2022-11-01","kind":"disposition_to_issuer","acquired":false,"shares":1004,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022."}],"balance_after":28820,"source":{"system":"sec-edgar","filing":"0000899243-22-035039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924322035039/doc4.xml","form_type":"4"}},{"id":2125198,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-03T21:14:08.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":37840,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option fully vests on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) on June 10, 2023."}],"balance_after":37840,"derivative":{"exercise_price":9.1,"expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":37840},"source":{"system":"sec-edgar","filing":"0000899243-22-035058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035058/doc4.xml","form_type":"4"}},{"id":2125197,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-03T21:14:08.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":13994,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":13994,"derivative":{"exercise_price":13.24,"expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":13994},"source":{"system":"sec-edgar","filing":"0000899243-22-035058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035058/doc4.xml","form_type":"4"}},{"id":2125196,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-03T21:14:08.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":10565,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":10565,"derivative":{"exercise_price":13.49,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":10565},"source":{"system":"sec-edgar","filing":"0000899243-22-035058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035058/doc4.xml","form_type":"4"}},{"id":2125195,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-03T21:14:08.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":17427,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":17427,"derivative":{"exercise_price":13.03,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":17427},"source":{"system":"sec-edgar","filing":"0000899243-22-035058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035058/doc4.xml","form_type":"4"}},{"id":2125194,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-03T21:14:08.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":10590,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":10590,"derivative":{"exercise_price":22.47,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":10590},"source":{"system":"sec-edgar","filing":"0000899243-22-035058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035058/doc4.xml","form_type":"4"}},{"id":2125193,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-03T21:14:08.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":10513,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":10513,"derivative":{"exercise_price":13.02,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":10513},"source":{"system":"sec-edgar","filing":"0000899243-22-035058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035058/doc4.xml","form_type":"4"}},{"id":2125192,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-03T21:14:08.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":9970,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":9970,"derivative":{"exercise_price":13.69,"expiration_date":"2026-05-23","underlying":"Common Stock","underlying_shares":9970},"source":{"system":"sec-edgar","filing":"0000899243-22-035058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035058/doc4.xml","form_type":"4"}},{"id":2125191,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-03T21:14:08.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":11789,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":11789,"derivative":{"exercise_price":10.3,"expiration_date":"2025-04-24","underlying":"Common Stock","underlying_shares":11789},"source":{"system":"sec-edgar","filing":"0000899243-22-035058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035058/doc4.xml","form_type":"4"}},{"id":2125190,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-03T21:14:08.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":14178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":14178,"derivative":{"exercise_price":7.75,"expiration_date":"2024-06-04","underlying":"Common Stock","underlying_shares":14178},"source":{"system":"sec-edgar","filing":"0000899243-22-035058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035058/doc4.xml","form_type":"4"}},{"id":2125189,"issuer":{"id":5294,"kind":"organization","name":"OmniAb, Inc."},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-03T21:14:08.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":172512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 8,753 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 22,538 earn-out shares subject to forfeiture provisions described in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. (\"Legacy OmniAb\"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the \"Merger Agreement\"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement."}],"balance_after":172512,"source":{"system":"sec-edgar","filing":"0000899243-22-035058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503062/000089924322035058/doc4.xml","form_type":"4"}},{"id":2234856,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-13T22:45:15.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":4340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":4340,"derivative":{"exercise_price":79.29,"expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":4340},"source":{"system":"sec-edgar","filing":"0000886163-22-000078","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000078/edgardoc.xml","form_type":"4"}},{"id":2234855,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T22:45:15.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":1004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":29824,"source":{"system":"sec-edgar","filing":"0000886163-22-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616322000078/edgardoc.xml","form_type":"4"}},{"id":2680002,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-08T01:23:28.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":3269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":3269,"derivative":{"exercise_price":115.39,"expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":3269},"source":{"system":"sec-edgar","filing":"0000886163-21-000088","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000088/edgardoc.xml","form_type":"4"}},{"id":2680001,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T01:23:28.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":28820,"source":{"system":"sec-edgar","filing":"0000886163-21-000088","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616321000088/edgardoc.xml","form_type":"4"}},{"id":2993472,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-04T21:19:16.000Z","date":"2020-11-02","kind":"purchase","acquired":true,"shares":1000,"price":82.52,"value":82520.0,"ownership":{"direct":true},"balance_after":28190,"source":{"system":"sec-edgar","filing":"0000886163-20-000118","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000118/edgardoc.xml","form_type":"4"}},{"id":3112433,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-12T22:32:29.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":2468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2468,"derivative":{"exercise_price":117.58,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":2468},"source":{"system":"sec-edgar","filing":"0000886163-20-000074","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000074/edgardoc.xml","form_type":"4"}},{"id":3112432,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T22:32:29.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":27190,"source":{"system":"sec-edgar","filing":"0000886163-20-000074","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616320000074/edgardoc.xml","form_type":"4"}},{"id":3447809,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-05T22:56:39.000Z","date":"2019-08-02","kind":"purchase","acquired":true,"shares":1000,"price":95.98,"value":95980.0,"ownership":{"direct":true},"balance_after":26359,"source":{"system":"sec-edgar","filing":"0000886163-19-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000136/edgardoc.xml","form_type":"4"}},{"id":3497897,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-06-07T22:44:19.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":4071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 06, 2019.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":4071,"derivative":{"exercise_price":113.59,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":4071},"source":{"system":"sec-edgar","filing":"0000886163-19-000103","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000103/edgardoc.xml","form_type":"4"}},{"id":3497896,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T22:44:19.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 06, 2019. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":25359,"source":{"system":"sec-edgar","filing":"0000886163-19-000103","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616319000103/edgardoc.xml","form_type":"4"}},{"id":3840833,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-08-17T23:37:21.000Z","date":"2018-08-16","kind":"exercise","acquired":false,"shares":7335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 11, 2013, and fully vested on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":32.3,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":7335},"source":{"system":"sec-edgar","filing":"0000886163-18-000120","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000120/edgardoc.xml","form_type":"4"}},{"id":3840832,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-08-17T23:37:21.000Z","date":"2018-08-16","kind":"exercise","acquired":false,"shares":7335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 31, 2012, and fully vested on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":12.53,"expiration_date":"2022-05-31","underlying":"Common Stock","underlying_shares":7335},"source":{"system":"sec-edgar","filing":"0000886163-18-000120","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000120/edgardoc.xml","form_type":"4"}},{"id":3840831,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-08-17T23:37:21.000Z","date":"2018-08-16","kind":"exercise","acquired":false,"shares":7335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and fully vested on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":10.12,"expiration_date":"2021-06-01","underlying":"Common Stock","underlying_shares":7335},"source":{"system":"sec-edgar","filing":"0000886163-18-000120","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000120/edgardoc.xml","form_type":"4"}},{"id":3840830,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-08-17T23:37:21.000Z","date":"2018-08-16","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in 36 successive monthly installments upon completion of each calendar month of service beginning on the grant date."}],"balance_after":0,"derivative":{"exercise_price":9.6,"expiration_date":"2020-10-07","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000886163-18-000120","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000120/edgardoc.xml","form_type":"4"}},{"id":3840829,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T23:37:21.000Z","date":"2018-08-16","kind":"sale","acquired":false,"shares":42287,"price":240.0456,"value":10150808.2872,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.31 to $242.68, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24524,"source":{"system":"sec-edgar","filing":"0000886163-18-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000120/edgardoc.xml","form_type":"4"}},{"id":3840828,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T23:37:21.000Z","date":"2018-08-16","kind":"exercise","acquired":true,"shares":7335,"price":32.3,"value":236920.5,"ownership":{"direct":true},"balance_after":66811,"source":{"system":"sec-edgar","filing":"0000886163-18-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000120/edgardoc.xml","form_type":"4"}},{"id":3840827,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T23:37:21.000Z","date":"2018-08-16","kind":"exercise","acquired":true,"shares":7335,"price":12.53,"value":91907.55,"ownership":{"direct":true},"balance_after":59476,"source":{"system":"sec-edgar","filing":"0000886163-18-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000120/edgardoc.xml","form_type":"4"}},{"id":3840826,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T23:37:21.000Z","date":"2018-08-16","kind":"exercise","acquired":true,"shares":7335,"price":10.12,"value":74230.2,"ownership":{"direct":true},"balance_after":52141,"source":{"system":"sec-edgar","filing":"0000886163-18-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000120/edgardoc.xml","form_type":"4"}},{"id":3840825,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T23:37:21.000Z","date":"2018-08-16","kind":"exercise","acquired":true,"shares":5000,"price":9.6,"value":48000.0,"ownership":{"direct":true},"balance_after":44806,"source":{"system":"sec-edgar","filing":"0000886163-18-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000120/edgardoc.xml","form_type":"4"}},{"id":3876962,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-03T22:37:21.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":2474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed to correct the exercise price listed in item 2 of Table II in order to reflect the market closing price on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2474,"derivative":{"exercise_price":195.91,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":2474},"source":{"system":"sec-edgar","filing":"0000886163-18-000095","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616318000095/edgardoc.xml","form_type":"4/A","original_submission_date":"2018-06-21"}},{"id":3886514,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-21T20:46:32.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":2474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2474,"derivative":{"exercise_price":76.77,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":2474},"source":{"system":"sec-edgar","filing":"0000899243-18-017610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924318017610/doc4.xml","form_type":"4"}},{"id":3886513,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-21T20:46:32.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":39806,"source":{"system":"sec-edgar","filing":"0000899243-18-017610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000089924318017610/doc4.xml","form_type":"4"}},{"id":4104095,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-08T19:09:51.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":3.98,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001140361-18-001275","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036118001275/doc1.xml","form_type":"4"}},{"id":4187355,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-10-12T18:36:08.000Z","date":"2017-10-10","kind":"sale","acquired":false,"shares":1202,"price":4.2418,"value":5098.6436,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit (\"RSU\") award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,375 RSUs. The Reporting Person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."}],"balance_after":68336,"source":{"system":"sec-edgar","filing":"0001140361-17-038568","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117038568/doc1.xml","form_type":"4"}},{"id":4187354,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-10-12T18:36:08.000Z","date":"2017-10-10","kind":"sale","acquired":false,"shares":46,"price":4.27,"value":196.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit (\"RSU\") award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 54,375 RSUs. The Reporting Person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."}],"balance_after":69538,"source":{"system":"sec-edgar","filing":"0001140361-17-038568","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117038568/doc1.xml","form_type":"4"}},{"id":4188905,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-10T19:28:48.000Z","date":"2017-10-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.36,"expiration_date":"2027-10-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-17-038099","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117038099/doc1.xml","form_type":"4"}},{"id":4188904,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-10-10T19:28:48.000Z","date":"2017-10-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 57,500 RSUs."}],"balance_after":69584,"source":{"system":"sec-edgar","filing":"0001140361-17-038099","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117038099/doc1.xml","form_type":"4"}},{"id":4303833,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-05-27T00:17:20.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":2456,"price":113.5,"value":278756.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 25, 2017.  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":2456,"derivative":{"exercise_price":113.5,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":2456},"source":{"system":"sec-edgar","filing":"0000886163-17-000074","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616317000074/edgardoc.xml","form_type":"4"}},{"id":4303832,"issuer":{"id":3825,"kind":"organization","name":"LIGAND PHARMACEUTICALS INC","symbol":"LGND"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-27T00:17:20.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired by a grant of the Board of Directors of the Company at their annual meeting on May 25, 2017  Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant."}],"balance_after":39313,"source":{"system":"sec-edgar","filing":"0000886163-17-000074","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886163/000088616317000074/edgardoc.xml","form_type":"4"}},{"id":4345503,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-25T18:12:43.000Z","date":"2017-04-23","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":3.73,"expiration_date":"2027-04-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001140361-17-016767","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117016767/doc1.xml","form_type":"4"}},{"id":4345502,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-04-25T18:12:43.000Z","date":"2017-04-23","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 32,500 RSUs."}],"balance_after":44584,"source":{"system":"sec-edgar","filing":"0001140361-17-016767","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117016767/doc1.xml","form_type":"4"}},{"id":4357952,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-04-05T19:40:49.000Z","date":"2017-04-04","kind":"sale","acquired":false,"shares":5711,"price":9.0582,"value":51731.3802,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,500 restricted stock units (\"RSUs\").  The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."}],"balance_after":24584,"source":{"system":"sec-edgar","filing":"0001140361-17-015048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117015048/doc1.xml","form_type":"4"}},{"id":4357951,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-04-05T19:40:49.000Z","date":"2017-04-04","kind":"sale","acquired":false,"shares":43,"price":8.8743,"value":381.5949,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,500 restricted stock units (\"RSUs\").  The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."}],"balance_after":30295,"source":{"system":"sec-edgar","filing":"0001140361-17-015048","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117015048/doc1.xml","form_type":"4"}},{"id":4498238,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-05T19:08:49.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":65000,"derivative":{"exercise_price":7.66,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001140361-17-000852","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117000852/doc1.xml","form_type":"4"}},{"id":4581437,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":111874,"kind":"person","name":"Patel Sunil","position":1,"cik":"0001503062","reported_name":"Patel Sunil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-10-11T21:41:56.000Z","date":"2016-10-09","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 27,500 restricted stock units."}],"balance_after":30338,"source":{"system":"sec-edgar","filing":"0001140361-16-082538","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036116082538/doc1.xml","form_type":"4"}}]}